Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.

Enabled by our proprietary drug discovery platform, Deciphera has developed a diverse pipeline of wholly-owned drug candidates. QINLOCK® (ripretinib) is Deciphera’s first FDA approved switch control kinase inhibitor developed for the treatment of adult patients with advanced GIST who have received prior treatment with three or more kinase inhibitors, including imatinib. QINLOCK is approved for 4th line GIST in the United States, Australia, Canada, China, Hong Kong, Switzerland, and Taiwan.

We offer an outstanding culture and opportunity for personal and professional growth based on our “PATHS” Core Values:

• Patients – We are committed to improving the lives of patients living with cancer. They are the driving force behind everything we do.
• Accountability – We demand accountability for our actions, behaviors, and performance. We recognize our duty to maintain a culture that embraces the uniqueness of our people and finds strength in our differences.
• Transparency – We strive to provide full visibility to internal and external stakeholders for a complete picture of what we are doing and why.
• Honesty and Integrity – Trust and mutual respect are essential aspects of our culture. We act with honesty and integrity in all facets of our business, and this serves as the foundation of our work and interactions with others.
• Stewardship – We are respectful of the resources entrusted to us by the investment community. We act thoughtfully and allocate resources responsibly in seeking to create value for our shareholders.

“How” we work together and the behaviors that we show up with each day are critical to maintaining our positive culture. Our behavioral expectations align with our values to elevate and drive individual and team performance:

• Lead from where you are – regardless of role or level, we motivate each other to achieve common goals.
• Drive business results – we navigate forward with our eye on the highest priorities.
• Partner and collaborate – we cultivate relationships and value ideas, regardless of where they are coming from, to achieve more together.
• Continuously evolve and improve – we try, we learn, we revise and try again.

The Role: Associate Director – QINLOCK Marketing

Deciphera is seeking a seasoned, dynamic, and experienced marketer with extensive commercial oncology experience to lead marketing initiatives across healthcare provider and consumer channels to support the company’s lead asset, QINLOCK (ripretinib) the first and only broad-spectrum KIT and PDGFRA switch-control kinase inhibitor engineered to block the drivers of resistance in advanced gastrointestinal stromal tumor (GIST). QINLOCK is currently approved for the treatment of adult patients with advanced GIST who have received prior treatment with 3 or more kinase inhibitors, including imatinib. The U.S. Food and Drug Administration (FDA) has also recently granted Breakthrough Therapy Designation (BTD) for QINLOCK for the treatment of adult patients with unresectable or metastatic GIST who received prior treatment with imatinib, and who harbor a KIT exon 11 mutation and co-occurring KIT exon 17 and/or 18 mutations (KIT exon 11+17/18 mutations), based on the ctDNA results from the Phase 3 INTRIGUE study. Reporting to the QINLOCK Brand Lead, this position will help with the development and implementation of the QINLOCK brand strategy, lead the development of personal and non-personal tactics and collaborate with functional and cross-functional partners to realize brand objectives and goals. This is a critical commercial role that will be instrumental to the continued commercialization success of QINLOCK in the US GIST marketplace.

What You’ll Do:

• Lead the development and implementation of the QINLOCK promotional plan for HCP audiences across, personal, non-personal promotion/digital, and peer-to-peer channels, and the consumer plan ensuring alignment with brand strategy
• Be a brand champion – assist in motivating and exciting the commercial functional team (Sales, Market Access, Training, Operations, Market Research and Analytics) and the company to help drive success of the QINLOCK across approved indications
• Play a key role in the annual brand/tactical planning process by shaping the strategic plan, and own the tactical plan and budget required to achieve the brands objectives
• Plan and oversee the development of advertising and promotional materials and activities including print, online, and other personal and non-personal promotional efforts in accordance with regulatory requirements
• Develop collaborative working relationships and serve as the day-to-day point of contact with external agency partners and internal cross-functional partners
• Ensure legal/regulatory compliance and medical accuracy of all promotional initiatives, tactics and marketing materials
• Assist in planning and execution for QINLOCK label updates and potential future indications
• Work closely with the cross functional team to roll out of marketing campaigns/messages, and guidance to the field team through plan of action meetings (POA)
• Partner with Brand Insights to identify market research and insight needs for QINLOCK to develop appropriate studies, and analyze customer insights, monitor brand performance and competitive dynamics to inform/adjust marketing/brand strategy and address customer needs
• Partner with Analytics and internal stakeholders to define success metrics and implement appropriate KPIs to monitor and measure the success of personal and non-personal promotion tactics and recommend modifications / adjustments as appropriate to ensure highest ROIs
• Closely manage marketing budgets to ensure expenditures are aligned with the brand plan

What You’ll Bring:

• Proactive, results oriented, self-starter motivated by the desire to do the right thing for the patients and their caregivers
• Bachelor’s degree in a business-related and/or life sciences field required. An MBA or advanced degree preferred
• 4+ years of prior in-line HCP Marketing and related experience in the pharmaceutical industry
• 5+ years of experience in pharmaceutical and/or healthcare industry with experience in one or more of the following: brand marketing, sales, managed markets, pricing or market research/analytics, strategic planning
• Oncology experience is a must. Launch and knowledge of oral oncolytics is preferred
• Extensive knowledge of medical, regulatory, legal review process
• Comfortable working in a fast paced, constantly evolving start-up environment

What Deciphera will Bring:

Deciphera offers competitive compensation, including equity-based compensation, and a comprehensive benefits package that includes the following:

• Non-accrual paid time off
• Summer vacation bonus
• Summer and winter shutdowns
• An annual lifestyle allowance
• Monthly cell phone stipend
• Internal rewards and recognition program
• Munch and learns
• Medical, Dental, and Vision Insurance
• 401(k) retirement plan
• Life and Supplemental life insurance for family
• ESPP offering
• Health savings account
• Flexible spending account for either health care and/or dependent care.

Deciphera (NASDAQ: DCPH) is a publicly traded company headquartered in Waltham, Massachusetts. Our state-of-the-art research facility is located in Lawrence, Kansas and our European operations are run out of Switzerland.

EQUAL EMPLOYMENT OPPORTUNITY INFORMATION

Deciphera is committed to equal employment opportunity and values diversity. To ensure that we comply with reporting requirements and to learn more about how we can increase diversity in our candidate pool, we invite you to voluntarily provide demographic information in a confidential survey at the end of this application. Providing this information is optional. It will not be accessible or used in the hiring process, and has no effect on your opportunity for employment. This information will also be treated confidentially. Our commitment to increasing diversity in our candidate pool does not affect our commitment to equal employment opportunity, including our ongoing commitment to make all hiring and other employment decisions solely on a nondiscriminatory basis.